Abstract: A driving circuit includes a driving control signal generation circuit and a multi-channel output circuit; the multi-channel output circuit includes N stage of output sub-circuits; N is an integer greater than 1; the driving control signal generation circuit is configured to generate a driving control signal, and the driving control signal is output through the driving control signal output terminal; an nth output sub-circuit is electrically connected to the driving control signal output terminal, an nth output clock signal line and an nth driving signal output terminal respectively, the nth output sub-circuit is configured to control the nth output clock signal line to provide an nth output clock signal to the nth driving signal output terminal under the control of the driving control signal; n is a positive integer less than or equal to N.

Abstract: Disclosed is a shift register including: an input sub-circuit, an output sub-circuit and a first control sub-circuit, wherein the input sub-circuit is electrically connected to a signal input end and a pull-up node, and is configured to provide a signal to the pull-up node under the control of a signal from the signal input end; the output sub-circuit is electrically connected to a first output end, the pull-up node and a clock signal end, and is configured to provide a signal from the clock signal end to the first output end under the control of a signal from the pull-up node; and the first control sub-circuit is electrically connected to a control signal end and a signal input end, and is configured to provide a signal from the control signal end to the signal input end under the control of the signal from the control signal end.

Abstract: A shift-register unit, a grid driving circuit and a displaying device, which relates to the technical field of displaying. In the present disclosure, the oxide-semiconductor layers of the oxide thin-film transistors may be delimited into regions according to the total channel widths and the channel lengths required by the oxide thin-film transistors in the shift-register unit, wherein the sum of the widths of the independent semiconductor branches obtained by the delimitation is equal to the required total channel width. Accordingly, one oxide thin-film transistor can realize the required total channel width by using the one or more semiconductor branches, to ensure the normal operation of the oxide thin-film transistor, whereby the oxide-semiconductor layers of the different oxide thin-film transistors can be configured differently, to realize the purpose of reducing the border frame of the displaying device.

Abstract: A response method for continuous operations and a device, where an electronic device detects a first operation triggered by a user at a first moment, and executes a response action corresponding to the first operation; detects a second operation triggered by the user at a second moment, where the second moment is later than the first moment; and if execution duration of the response action corresponding to the first operation at the second moment is greater than or equal to preset duration, ends the response action corresponding to the first operation, and executes a response action corresponding to the second operation, where the preset duration is less than single execution duration, and the single execution duration is preset sustained duration of the response action corresponding to the first operation.

Abstract: The provided are sealing components, a focused ultrasound treatment system and an operation method thereof, and a semi-dry acoustic coupling apparatus. The focused ultrasound treatment system includes a medium container with two ends opened, a waterproof adhesive ring, an ultrasound emission device, a gas pressure increase/decrease component, a coupling fluid increase/decrease component, and a pressure control module, where a first connecting surface of the waterproof adhesive ring is configured to attach to the skin of a patient; a second connecting surface of the waterproof adhesive ring is bonded with a first end of the medium container, and a second end of the medium container is tightly connected with a shell of the ultrasound emission device. The provided has advantages of simple device, reduced attenuation, thorough coupling, improved efficacy, reduced risk, and no damage to an ultrasonic imaging probe.

Abstract: A display method includes displaying an application on a screen in a first mode and receiving an operation performed on the screen, where the operation is any operation in a plurality of consecutive operations. The consecutive operations include any one or any combination of a same operation mode, a same operation object, and a same region for an operation object, and the same operation mode includes either or both of a same operation gesture and a same operation direction for an operation gesture. Switching, in response to the operation, display of the application from the first mode to a second mode, where each of the first mode and the second mode is any one of a full-screen mode, a window mode, a card mode, or a floating ball mode.

Abstract: The provided are sealing components, a focused ultrasound treatment system and an operation method thereof, and a semi-dry acoustic coupling apparatus. The focused ultrasound treatment system includes a medium container with two ends opened, a waterproof adhesive ring, an ultrasound emission device, a gas pressure increase/decrease component, a coupling fluid increase/decrease component, and a pressure control module, where a first connecting surface of the waterproof adhesive ring is configured to attach to the skin of a patient; a second connecting surface of the waterproof adhesive ring is bonded with a first end of the medium container, and a second end of the medium container is tightly connected with a shell of the ultrasound emission device. The provided has advantages of simple device, reduced attenuation, thorough coupling, improved efficacy, reduced risk, and no damage to an ultrasonic imaging probe.

Abstract: Provided are a flexible material based on resource utilization of waste finished leathers and waste fabrics and a preparation method thereof. The flexible material is prepared form raw materials including the following components in parts by weight: 50 parts to 70 parts of a waste rubber powder, 10 parts to 20 parts of a waste polyester nano-powder, 10 parts to 20 parts of a waste leather powder, and 8 parts to 12 parts of an epoxidized natural rubber (ENR) curing agent.

Abstract: An array substrate includes a base substrate, including a display area and a peripheral area; a driving circuit layer, including a plurality of data lines and a plurality of scanning lines; a metal layer, including a plurality of metal blocks located at intersections of the data lines and the scanning lines; a signal lead, including a data lead and a scanning lead, where the data lead is connected to the data lines and is arranged in a same layer as the data lines, and the scanning lead is arranged in a same layer as the scanning lines; a touch control lead, located at the side of the base substrate and located in the peripheral area, where the touch control lead is connected to the touch control signal lines and is arranged in a same layer as the touch control signal lines.

Abstract: An anti-B7-H3 antibody, a preparation method therefor, a conjugate and an application thereof. The anti-B7-H3 antibody comprises a complementarity determining region: one or more of heavy chain CDR1, heavy chain CDR2, and heavy chain CDR3, and/or one or more of light chain CDR1, light chain CDR2, and light chain CDR3. A sequence of the complementarity determining region is as described in the specification. The anti-B7-H3 antibody is a fully human antibody, has a unique antigen binding epitope, and can specifically bind B7-H3 antigen on tumor cells. Moreover, the antibody can rapidly internalize into cells after binding to tumor cells, and can be used for ADC drug development to obtain better anti-tumor activity and efficacy to achieve the purpose of treating cancers.

Abstract: An array substrate includes a base substrate, including a display area and a peripheral area; a driving circuit layer, located at one side of the base substrate and including a plurality of data lines and a plurality of scanning lines, where the plurality of data lines extend along a first direction and are arranged at intervals along a second direction, the plurality of scanning lines extend along the second direction and are arranged at intervals along the first direction, and the data line and the scanning line intersect with each other to define a plurality of sub-pixel areas; and a metal layer, located at one side of the driving circuit layer away from the base substrate, where the metal layer includes a plurality of metal blocks arranged at intervals, and the metal block is located at an intersection of the data line and the scanning line.

Abstract: Disclosed are an anti-DLL3 antibody and a preparation method therefor, a drug conjugate and application thereof. The anti-DLL3 antibody in the present invention has good internalization activity, has better binding activity with human DLL3 protein, and has strong affinity at the protein level. The antibody conjugated drug targeting DLL3 in the present invention has good druggability, biological activity, and anti-tumor activity in vitro and vivo, and can achieve an application of cytotoxic drugs in treating tumor patients comprising SCLC and having neuroendocrine characteristics.

Abstract: A joint imaging system based on unmanned aerial vehicle platform and an image enhancement fusion method are provided. The system includes a flying unit as a load platform, a shutter control system for controlling the operation of a load camera, a posture control system for recording the movement track and POS data of the flying unit, an airborne image transmission system for communicating with ground equipment, and an onboard computing unit with an image processing module for receiving the output images and performing image processing and fusion.

Abstract: The provided are sealing components, a focused ultrasound treatment system and an operation method thereof, and a semi-dry acoustic coupling apparatus. The focused ultrasound treatment system includes a medium container with two ends opened, a waterproof adhesive ring, an ultrasound emission device, a gas pressure increase/decrease component, a coupling fluid increase/decrease component, and a pressure control module, where a first connecting surface of the waterproof adhesive ring is configured to attach to the skin of a patient; a second connecting surface of the waterproof adhesive ring is bonded with a first end of the medium container, and a second end of the medium container is tightly connected with a shell of the ultrasound emission device. The provided has advantages of simple device, reduced attenuation, thorough coupling, improved efficacy, reduced risk, and no damage to an ultrasonic imaging probe.

Abstract: Provided in the embodiments are a transfer structure and a method thereof, and a transfer device and a manufacturing method thereof. The transfer structure includes: a first electrode, a piezoelectric layer, a second electrode and an adhesive layer stacked on a substrate in sequence, wherein the first electrode and the second electrode are insulated from each other. The transfer structure further includes: a position-limiting layer, wherein the position-limiting layer includes a cavity; the piezoelectric layer and at least part of the adhesive layer are located in the cavity of the position-limiting layer; and in the direction perpendicular to the substrate, the distance between the surface, away from the substrate, of the position-limiting layer and the substrate is greater than the distance between the surface, away from the substrate, of the adhesive layer and the substrate.

Abstract: A TROP2 targeting antibody-drug conjugate, and a preparation method and use therefor. The antibody-drug conjugate is shown in formula I. Said type of compound has a good targeting property, a good inhibitory effect on tumor cells positively expressing TROP2, and good druggability and high safety. The present antibody drug conjugate has an inhibitory effect on TROP2, and also a good inhibitory effect on at least one of NCI-N87, MDA-MB-468 and BXPC3 cells.

Abstract: A shift-register unit, a grid driving circuit and a displaying device, which relates to the technical field of displaying. In the present disclosure, the oxide-semiconductor layers of the oxide thin-film transistors may be delimited into regions according to the total channel widths and the channel lengths required by the oxide thin-film transistors in the shift-register unit, wherein the sum of the widths of the independent semiconductor branches obtained by the delimitation is equal to the required total channel width. Accordingly, one oxide thin-film transistor can realize the required total channel width by using the one or more semiconductor branches, to ensure the normal operation of the oxide thin-film transistor, whereby the oxide-semiconductor layers of the different oxide thin-film transistors can be configured differently, to realize the purpose of reducing the border frame of the displaying device.

Abstract: An electronic device displays an application window in a floating window state, where the application window includes a first control. Following a first sliding operation starting from the first control, the electronic device may move the application window along a sliding track of the first sliding operation, where the first sliding operation is a first movement in a first direction. The electronic device may display the application window in a full-screen state in response to a first lifting operation after the first movement, where before displaying the application window in the full-screen state, the electronic device further continues to move the application window in the first direction in response to the first lifting operation after the first movement, where a window size of the application window gradually increases in a moving process until the application window is in the full-screen state.

Abstract: A controller (600) for a radiotherapy device (320) is provided; the radiotherapy device (320) being configured to provide therapeutic radiation to a patient (308) via a source (300) of therapeutic radiation, wherein the radiotherapy device (320) comprises a first rotatable member (304), the rotation of which can alter a physical attribute of the therapeutic radiation provided, and a patient support member (310), which is linearly moveable in at least one of a longitudinal direction and a lateral direction. The controller (600) comprises a first rotatable actuator (608) for controlling a movement of the first rotatable member (304) and a second actuator (620) for controlling a movement of the patient support member (310).

Abstract: An antibody-drug conjugate, and an intermediate thereof, a preparation method therefor, and an application thereof. Provided is an antibody-drug conjugate as represented by formula I. The compound has good targetability, has a good inhibitory effect on HER3-positive tumor cells, and has good druggability and high safety. The antibody-drug conjugate has an inhibitory effect on HER3, has an inhibitory effect on SK-BR-3 and SW620 cells, and also has a good inhibitory effect on at least one of 22Rv1, LNCaP, NCI-H820, OVCAR-8, and HCC827 cells.